CMTTdb

An integrated database for cancer molecular targeted thearpies

View Agent


Agent Info
Agent:erlotinib
Synonyms:Erlotinin;Tarceva;Erlotinib Base;AQ4;OSI 744;R 1415;CP 358,774;CP-358774;Erlotinib(Tarceva);Tarceva (TN);CP-358,774;Erlotinib, OS-774;N-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine;[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine;4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline;4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline
Drug Status For Certain Diseases:Metastatic or locally advanced NSCLC, with EGFR exon 19 deletion or L858R substitution;Metastatic or advanced pancreatic cancer in combination with gemcitabine(Approved)
Classification:1st-generation EGFR TKI,a receptor tyrosine kinase inhibitor with specificity for the EGFR/HER1
Target:Epidermal growth factor receptor
KEGG Pathway:NA
Wiki Pathway:miR-targeted genes in epithelium - TarBase
Spinal Cord Injury
Focal Adhesion
Arylhydrocarbon receptor (AhR) signaling pathway
Signaling by ERBB4
Extracellular vesicle-mediated signaling in recipient cells
Hair Follicle Development
Aryl Hydrocarbon Receptor Pathway
Regulation of Actin Cytoskeleton
PIP3 activates AKT signaling
Signaling Pathways in Glioblastoma
miR-targeted genes in lymphocytes - TarBase
EGF/EGFR Signaling Pathway
L1CAM interactions
Signaling by EGFR
Integrated Breast Cancer Pathway
Integrated Pancreatic Cancer Pathway
Aryl Hydrocarbon Receptor
Nanoparticle-mediated activation of receptor signaling
Bladder Cancer
miR-targeted genes in muscle cell - TarBase
AGE/RAGE pathway
Gastric cancer network 2
Gastrin-CREB signalling pathway via PKC and MAPK
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
MAPK Signaling Pathway
Hair Follicle Development
Signaling by ERBB2
ErbB Signaling Pathway